Founded in 1990, Pharmexa is a biotechnology company focusing on the development of novel immunotherapy drugs to treat oncological and inflammatory diseases. Pharmexa's aim is to become the leading active immunotherapy company in the world, because the company believes this position will be attractive to hold in the second half of this decade.